RAB22A and neoplasm: In addition, RAB22A inactivates RAB7 to suppress the fusion of Rafeesome with lysosome, and the inner vesicles bearing activated STING are secreted as R-EVs, which activate the IFNβ pathway in recipient cells in the tumor microenvironment to execute antitumor immunity.